The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic

The Emergency Use Authorization (EUA) originated in 2004 because of the need for emergency medical countermeasures (MCMs) against potential bioterrorist attacks. The EUA also proved useful in dealing with subsequent pandemics and has emerged as a critical regulatory pathway for therapeutics and vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Allan, Witek, Theodore J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401346/
https://www.ncbi.nlm.nih.gov/pubmed/34453703
http://dx.doi.org/10.1007/s40290-021-00397-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401346/
https://www.ncbi.nlm.nih.gov/pubmed/34453703
http://dx.doi.org/10.1007/s40290-021-00397-6

Ejemplares similares